Literature DB >> 10423298

Cell allocation and chromosomal complement of parthenogenetic and IVF bovine embryos.

A Van De Velde1, L Liu, P E Bols, M T Ysebaert, X Yang.   

Abstract

Considerable concerns exist regarding the quality of parthenogenetically activated embryos in terms of sufficient numbers of cells comprising the inner cell mass (ICM) and trophectoderm (TE) and the ploidy. Therefore, these two parameters were used to assess the quality of embryos derived from parthenogenetic activation by using calcium ionophore A23187 (CaI) followed by either 6-dimethylaminopurine (6-DMAP, 3.5 hr or 6.5 hr) or cycloheximide (CHX) plus cytochalasin D (CD). The conventional in vitro (IVF) produced embryos served as a control. Double staining of the parthenogenetic blastocysts showed that the total cell number (TC) of embryos from the 6-DMAP 3.5 hr (87.0 +/- 5.3) and CHX+CD (79.0 +/- 6.1) groups was not different (P > 0.05), but was lower than that of control embryos (116.0 +/- 5.8, P < 0.001). The mean ratios of inner cell mass (ICM) and trophectoderm (TE) cells in the 6-DMAP 3.5 hr group (0.57 +/- 0.04) and the control IVF group (0.50 +/- 0. 02) did not differ significantly. Both were higher than those of the CHX+CD group (0.36 +/- 0.02; P < 0.05). Further analysis of chromosomal compositions of developing stage embryos at day four after IVF or parthenogenetic activation demonstrated that prolonged treatment with 6-DMAP for 6.5 hr resulted in a significantly lower percentage of diploid embryos and a significantly higher percentage of abnormal ploidy embryos compared to treatment with 6-DMAP for 3.5 hr or with CHX and IVF. In conclusion, parthenogenetic activation of bovine oocytes with CaI followed by 6-DMAP for 3.5 hr could produce better quality embryos in terms of total cell numbers, the number of cells allocated to the ICM, and the ploidy of embryos. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423298     DOI: 10.1002/(SICI)1098-2795(199909)54:1<57::AID-MRD8>3.0.CO;2-4

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  5 in total

1.  Centrosome amplification and chromosomal instability in human and animal parthenogenetic cell lines.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Sara Maffei; Gianluca Tettamanti; Arianna Vanelli; Sara Isaac; Amir Eden; Sergio Ledda; Magda de Eguileor; Fulvio Gandolfi
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  The use of parthenotegenetic and IVF bovine blastocysts as a model for the creation of human embryonic stem cells under defined conditions.

Authors:  R R Ruggeri; Y Watanabe; F Meirelles; F F Bressan; N Frantz; A Bos-Mikich
Journal:  J Assist Reprod Genet       Date:  2012-09-29       Impact factor: 3.412

3.  Efficient production and cellular characterization of sheep androgenetic embryos.

Authors:  Federica Zacchini; Marta Czernik; Domenico Iuso; Paola Toschi; Fiorella di Egidio; Pier Augusto Scapolo; Pasqualino Loi; Grazyna Ptak
Journal:  Cell Reprogram       Date:  2011-11-01       Impact factor: 1.987

4.  Parthenogenetic activation of bovine oocytes using bovine and murine phospholipase C zeta.

Authors:  Pablo J Ross; Zeki Beyhan; Amy E Iager; Sook-Young Yoon; Christopher Malcuit; Karl Schellander; Rafael A Fissore; Jose B Cibelli
Journal:  BMC Dev Biol       Date:  2008-02-19       Impact factor: 1.978

5.  Pretreatment of bovine sperm with dithiobutylamine (DTBA) significantly improves embryo development after ICSI.

Authors:  Tayita Suttirojpattana; Tamas Somfai; Satoko Matoba; Takashi Nagai; Rangsun Parnpai; Masaya Geshi
Journal:  J Reprod Dev       Date:  2016-08-14       Impact factor: 2.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.